Johnson Pharmacare [JOHNPHARMA] vs Beml Land Assets [BLAL] Detailed Stock Comparison

Johnson Pharmacare

BSE

Beml Land Assets

NSE

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Johnson Pharmacare wins in 7 metrics, Beml Land Assets wins in 7 metrics, with 1 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric	Johnson Pharmacare	Beml Land Assets	Better
P/E Ratio (TTM)	-79.00	-231.69	Beml Land Assets
Price-to-Book Ratio	0.72	785.55	Johnson Pharmacare
Debt-to-Equity Ratio	1.08	779.28	Johnson Pharmacare
PEG Ratio	0.79	-7.88	Beml Land Assets
EV/EBITDA	-99.79	-256.50	Beml Land Assets
Profit Margin (TTM)	0.00%	0.00%	Tie
Operating Margin (TTM)	127.68%	0.00%	Johnson Pharmacare
EBITDA Margin (TTM)	127.68%	N/A	N/A
Return on Equity	-1.04%	-337.59%	Johnson Pharmacare
Return on Assets (TTM)	-1.01%	-38.01%	Johnson Pharmacare
Free Cash Flow (TTM)	$-19.09M	$8.34M	Beml Land Assets
1-Year Return	-40.91%	-24.16%	Beml Land Assets
Price-to-Sales Ratio (TTM)	-130.32	N/A	N/A
Enterprise Value	$411.34M	$8.73B	Beml Land Assets
EV/Revenue Ratio	-123.38	N/A	N/A
Revenue per Share (TTM)	$0	$0	Beml Land Assets
Earnings per Share (Diluted)	$-0.01	$-1.04	Johnson Pharmacare
Beta (Stock Volatility)	-0.90	0.21	Johnson Pharmacare

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Johnson Pharmacare vs Beml Land Assets Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Johnson Pharmacare	-1.27%	-1.27%	-9.30%	-14.29%	-21.21%	-30.97%
Beml Land Assets	0.17%	1.78%	-1.71%	1.32%	0.23%	-11.06%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Johnson Pharmacare	-40.91%	1.30%	-83.98%	-83.98%	-83.98%	-83.98%
Beml Land Assets	-24.16%	-15.27%	-15.27%	-15.27%	-15.27%	-15.27%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Johnson Pharmacare (JOHNPHARMA): View Full Stock Overview

Beml Land Assets (BLAL): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Johnson Pharmacare vs Beml Land Assets

Metric	JOHNPHARMA	BLAL
Market Information
Market Cap i	₹434.50M	₹8.67B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	1,020,557	43,864
90 Day Avg. Volume i	1,067,967	46,664
Last Close	₹0.78	₹208.52
52 Week Range	₹0.76 - ₹1.44	₹180.50 - ₹292.50
% from 52W High	-45.83%	-28.71%
All-Time High	₹7.14 (Jan 03, 2022)	₹377.45 (Feb 05, 2024)
% from All-Time High	-89.08%	-44.76%
Growth Metrics
Quarterly Revenue Growth	N/A	N/A
Quarterly Earnings Growth	N/A	N/A
Financial Health
Profit Margin (TTM) i	0.00%	0.00%
Operating Margin (TTM) i	1.28%	0.00%
Return on Equity (TTM) i	-0.01%	-3.38%
Debt to Equity (MRQ) i	1.08	779.28
Cash & Liquidity
Book Value per Share (MRQ)	₹1.09	₹0.27
Cash per Share (MRQ)	₹0.00	₹0.00
Operating Cash Flow (TTM) i	₹-19,089,000	₹8.68M
Levered Free Cash Flow (TTM) i	₹-5,838,000	₹-37,473,000
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Johnson Pharmacare vs Beml Land Assets

Metric	JOHNPHARMA	BLAL
Price Ratios
P/E Ratio (TTM) i	-79.00	-231.69
Forward P/E i	N/A	N/A
PEG Ratio i	0.79	-7.88
Price to Sales (TTM) i	-130.32	N/A
Price to Book (MRQ) i	0.72	785.55
Market Capitalization
Market Capitalization i	₹434.50M	₹8.67B
Enterprise Value i	₹411.34M	₹8.73B
Enterprise Value Metrics
Enterprise to Revenue i	-123.38	N/A
Enterprise to EBITDA i	-99.79	-256.50
Risk & Other Metrics
Beta i	-0.90	0.21
Book Value per Share (MRQ) i	₹1.09	₹0.27

Financial Statements Comparison: Johnson Pharmacare vs Beml Land Assets

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	JOHNPHARMA	BLAL
Revenue/Sales i	₹0	₹0
Cost of Goods Sold i	₹0	₹1.18M
Gross Profit i	₹0	₹-1.18M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹-534,000	₹-2.25M
EBITDA i	₹-534,000	₹-2.07M
Pre-Tax Income i	₹-534,000	₹-4.19M
Income Tax i	N/A	₹0
Net Income (Profit) i	₹-534,000	₹-4.19M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	JOHNPHARMA	BLAL
Cash & Equivalents i	₹77,000	₹100,000
Total Current Assets i	₹156.34M	₹1.30M
Total Current Liabilities i	₹11.51M	₹1.00M
Long-Term Debt i	₹6.05M	₹0
Total Shareholders Equity i	₹561.69M	₹11.10M
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	N/A	N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	JOHNPHARMA	BLAL
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	JOHNPHARMA	BLAL
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	1,020,557	43,864
Average Daily Volume (90 Day) i	1,067,967	46,664
Shares Outstanding i	550.00M	41.64M
Float Shares i	484.32M	18.26M
% Held by Insiders i	0.06%	0.54%
% Held by Institutions i	0.00%	0.07%

Dividend Analysis & Yield Comparison: Johnson Pharmacare vs Beml Land Assets

Metric	JOHNPHARMA	BLAL
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Johnson Pharmacare [JOHNPHARMA] vs Beml Land Assets [BLAL] Detailed Stock Comparison